Eric A. Murphy
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Angiogenesis and VEGF in Cancer 4
- Melanoma and MAPK Pathways 3
- Fibroblast Growth Factor Research 2
- Oncology 5
- Colorectal Cancer Treatments and Studies 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- David A. Cheresh (10 shared papers)David J. Shields (6 shared papers)Sara M. Weis (5 shared papers)Lisette M. Acevedo (4 shared papers)Bharat K. Majeti (4 shared papers)Lea Scheppke (3 shared papers)Leo A. Barnes (3 shared papers)Wolfgang Wrasidlo (2 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Cancer Research (3 papers)Nature Medicine (2 papers)Journal of Clinical Oncology (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- United States
In The Last Decade
Eric A. Murphy
20 papers receiving 1.9k citations
Eric A. Murphy's Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 523
- Biomaterials 330
- Immunology and Allergy 121
- Molecular Biology 1.2k
- Oncology 344
Countries citing papers authored by Eric A. Murphy
This map shows the geographic impact of Eric A. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Murphy more than expected).
Fields of papers citing papers by Eric A. Murphy
This network shows the impact of papers produced by Eric A. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Murphy. The network helps show where Eric A. Murphy may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric A. Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A role for VEGF as a negative regulator of pericyte function and vessel maturation Hit paper breakdown → | 2008 | 501 |
| 2 | 2010 | 418 | |
| 3 | 2008 | 370 | |
| 4 | 1996 | 123 | |
| 5 | 2011 | 116 | |
| 6 | 2009 | 72 | |
| 7 | 2011 | 62 | |
| 8 | 2011 | 54 | |
| 9 | 2009 | 52 | |
| 10 | 2010 | 50 | |
| 11 | 2012 | 33 | |
| 12 | 2024 | 10 | |
| 13 | 2021 | 9 | |
| 14 | 2001 | 8 | |
| 15 | 2014 | 8 | |
| 16 | 2022 | 7 | |
| 17 | 2024 | 5 | |
| 18 | 2010 | 5 | |
| 19 | 2014 | 4 | |
| 20 | 2024 | 1 |
About Eric A. Murphy
Eric A. Murphy is a scholar working on Molecular Biology, Oncology, Cell Biology, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 20 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Melanoma and MAPK Pathways (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers), Lung Cancer Treatments and Mutations (3 papers), Colorectal Cancer Treatments and Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Cancer Research (523 citations), Biomaterials (330 citations), Immunology and Allergy (121 citations), Molecular Biology (1.2k citations) and Oncology (344 citations). Eric A. Murphy has collaborated with scholars based in United States. Frequent co-authors include David A. Cheresh, David J. Shields, Sara M. Weis, Lisette M. Acevedo, Bharat K. Majeti, Lea Scheppke, Leo A. Barnes, Wolfgang Wrasidlo, Joshua I. Greenberg and Jianhua Huang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research, Nature Medicine, Journal of Clinical Oncology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.